Sign in
TCBPW Stock Price, Chart, Stats & News
TC Biopharm (Holdings) Plc
Save
TC Biopharm (Holdings) Plc (TCBPW) does not currently pay a dividend.
1,282
Market cap
–
Current P/E
–
Forward P/E
TCBPW chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
TC Biopharm (Holdings) Plc is a biopharmaceutical firm currently in the clinical trial phase, dedicated to advancing immunotherapy treatments. Their core approach revolves around an innovative allogeneic gamma delta T cell platform. The company's development portfolio features OmnImmune, an unmodified cell therapy designed to treat acute myeloid leukemia, and ImmuniStim, another unmodified cell therapy undergoing development for COVID-19.
Similar securities
Based on sector and market capitalization
Report issue